Shire gets FDA approval to market ADHD drug for adults in U.S.

08/13/2004 | Scotsman (Edinburgh), The

Scotland's Shire Pharmaceuticals announced it has received approval from the FDA for the sale of its Adderall XR attention deficit hyperactivity disorder treatment for adults in the U.S. The company already has approval to market the drug for treatment of children and says it will begin marketing to adults immediately. Adderall XR is the most-prescribed brand for ADHD treatment in the states, and Shire says sales to adults could be double that for children.

View Full Article in:

Scotsman (Edinburgh), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX